The study showed a trend towards a slower decline of fasting C-peptide (marker of the endogen insulin secretion), and significantly lower insulin dose requirements after 12 months in the cholecalciferol supplemented new onsets than in a placebo group.
← all excerpts
Vitamin D and ω-3 Polyunsaturated Fatty Acids towards a Personalized Nutrition of Youth Diabetes: A Narrative Lecture.
1
—
—